Patent directory · USPTO A61K / A61P
Patents matching “Regents of the University of Minnesota”
446 pharma patents match "Regents of the University of Minnesota" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 446 pharmaceutical patents matching "Regents of the University of Minnesota" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11236360
Adeno-associated viruses engineered for selectable tropism
granted -
US 11208634
Deimmunized therapeutic compositions and methods
granted -
US 11147746
Hydrophobic dental surfaces
granted -
US 11130783
CD40 targeted peptides and uses thereof
granted -
US 11124541
Chimeric melanocortin ligands and methods of use thereof
granted -
US 11098109
Single-chain variable fragment anti-CD133 antibodies and uses thereof
granted -
US 11098100
Therapeutic compounds and methods
granted -
US 11098101
Therapeutic compounds and methods
granted -
US 11071787
Topiramate compositions and methods of making and using the same
granted -
US 11022602
Antibiotic-based conjugates and methods of use thereof
granted -
US 11014921
Therapeutic compounds and methods of use thereof
granted -
US 10995317
NK cells exhibiting an adaptive phenotype and methods for preparing and for using
granted -
US 10993959
Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)
granted -
US 10993419
Genetically modified cells, tissues, and organs for treating disease
granted -
US 10981951
Therapeutics for the treatment of glaucoma
granted -
US 10973812
Ataxia therapeutic compositions and methods
granted -
US 10973844
TALEN-based gene correction
granted -
US 10967062
Functionalized nanoparticles and methods of use thereof
granted -
US 10942183
Methods of detecting progesterone receptor and of detecting an expression level
granted -
US 10941433
Neurotransmitter transport in probiotics
granted -
US 10933042
Intravenous baclofen formulations and treatment methods
granted -
US 10925851
Use of Tosedostat and related compounds as analgesics
granted -
US 10899793
Melanocortin ligands and methods of use thereof
granted -
US 10894061
Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
granted